Researchers from the University of Oxford’s Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine.
Influenza is thought to be a highly variable virus, able to mutate and escape immunity built up in the population due to its circulation in previous seasons. However, influenza seasons tend to be dominated by a limited number of antigenically and genetically distinct influenza viruses. This creates a paradox as influenza is thought of as being highly variable while in reality influenza seasons are dominated by only a few strains.
Mathematical models produced in Professor Sunetra Gupta’s group at the University of Oxford over the past 20 years have sought to find an answer to this paradox. Finally, through a collaborative approach across multiple departments, the group believes they have the answer, demonstrated in a paper published today in Nature Communications.
Dr Craig Thompson said: ‘The integrated approach to vaccine design that we have applied to flu has to the potential to be applied to other previously intractable pathogens and could revolutionise the way we develop vaccines.’
Professor Sunetra Gupta said: ‘I think this work serves a good example of how evolutionary models can have translational impact. We have gone from a prediction of a mathematical model to a blueprint for a universal influenza vaccine. The outstanding teamwork coordinated by Dr Thompson is what made it all possible.’
The research team theorized that parts of the virus targeted by the immune system are, in fact, limited in variability and act as constraints on the evolution of the virus. Dr Craig Thompson in Professor Gupta’s group has now identified the location of these regions of limited variability. He has shown that such locations are targeted naturally by the immune system and through vaccination studies has shown that regions of influenza viruses that circulated in 2006 and 1977 were able to protect against infection with an influenza virus that last circulated in 1934.
The results of these studies can be exploited to create a novel type of ‘universal’ or broadly protective influenza vaccine, which once administered would provide lifelong protection against influenza. The team also hopes to apply the approach to other viruses such as HIV and HCV and believes that they can use it to produce a vaccine that protects against the common cold. The novel approach to vaccine design is outlined in the paper published in Nature Communications. Furthermore, such vaccines should be able to be produced in a low-cost manner, enabling healthcare providers such as the NHS to save money, unlike many new vaccines and drugs coming to the market.
This study also presents one of the first examples of where a mathematical model of the evolutionary dynamics of an infectious disease has led to the experimental identification of a novel vaccine target. The novel approach won an MRC Confidence in Concept Award in 2016, a Royal Society Translational Award in 2017 and an ERC Proof of Concept grant in 2018.
The WHO estimates that influenza kills 260,000-650,000 people and causes 3-5 million cases of severe illness each year. This burden typically falls on the elderly and young children, especially in developing countries. The best way to protect against influenza is through vaccination, although the problem with this is that the current influenza vaccine has to be administered each year and varies in its effectiveness.
The Latest on: Universal flu vaccine
via Google News
The Latest on: Universal flu vaccine
- Toward a universal influenza vaccineon March 5, 2021 at 3:53 pm
The development of a universal influenza vaccine is of paramount importance because seasonal vaccines vary in terms of protection. Darricarrère et al. have now moved a universal influenza vaccine one ...
- Researchers Make Headway on Universal Flu Vaccine Candidateon March 4, 2021 at 7:48 pm
A recent study published in Science Translational Medicine shows that a new flu vaccine appears to protect monkeys against influenza strains that are likely to cause a global pandemic, giving research ...
- A universal flu vaccine? Study suggests protection against multiple strains, perhaps for years, may be possibleon March 4, 2021 at 12:11 pm
A team of scientists has developed a flu vaccine that appears to work in monkeys. The positive results have prompted a small study to begin in humans.
- Funding for cycle routes and pathson March 3, 2021 at 10:12 pm
A new programme of cycling and walking schemes will be delivered after a council was awarded more than £1 million of funding from the Department for ...
- Influenza vaccine produces protective antibodies against diverse flu strains in animalson March 3, 2021 at 11:24 am
A series of nanoparticle-based vaccines elicits protective antibodies against various strains of the influenza virus in nonhuman primates, according to work from Nicole Darricarrère and colleagues.
- Vaccine shows signs of protection against dozen-plus flu strainson March 3, 2021 at 6:38 am
A vaccine candidate has demonstrated promising signs of protection against more than a dozen swine flu strains -- and more than a leading, commercially available vaccine. Its success in experiments ...
- A universal coronavirus vaccine could stop the next pandemicon March 2, 2021 at 10:03 pm
Coronaviruses have been responsible for three major pandemic threats, and it's likely many more are waiting in the shadows. A vaccine that protects against them all could stop a pandemic before it beg ...
- One year later, the 'new normal' is just everyday lifeon February 27, 2021 at 9:00 pm
The disruption of the past year can be tallied with certain numbers, but less tangible is what was lost with so many weeks in isolation, so many lives cut short.
- Highlights / universal influenza vaccineon February 27, 2021 at 9:30 am
CBC/Radio-Canada’s multilingual website highlighting the democratic and cultural values of Canadians of all origins.
via Bing News